Aerbio Announces Series A Fundraising Plan to Propel Next-Generation Sustainable Biotechnology

As of October 2024, Aerbio had successfully raised €31.25 million, complemented by an additional €5 million in secured loans.

This strategic move will accelerate the development of Aerbio’s state-of-the-art demonstration-scale facility and drive further expansion of its transformative (R)evolve™ platform, paving the way for full-scale commercial deployment.

Revolutionizing Biotechnology for a Sustainable Future

Aerbio is at the forefront of biotechnology innovation, transforming simple molecules into valuable products without the need for arable land or fossil fuels. With our groundbreaking (R)evolve™ platform, we’ve unlocked the potential of microbiology to convert carbon dioxide and hydrogen into valuable products. Our launching product is Proton™, a protein-rich ingredient poised to revolutionise food and animal nutrition industries.

“Our ambition knows no bounds,” said Kaspar Kristiansen, CEO of Aerbio. “Our Series A round is a bold statement in our conviction in our plan and our relentless pursuit of breaking new ground in biotechnology. We’re not just building a company—we’re turning biotechnology on its head, paving the way for a sustainable future where sugar-free fermentation is a reality.”

Propelling the Future of Sustainable Protein

The funds raised in this round will be crucial in completing our demonstration-scale facility, a pivotal milestone in Aerbio’s journey. This facility will provide the final validation needed before scaling up to full commercial operations. With the successful launch of our pilot facility and the recent appointment of board members, Aerbio has strong foundations build upon, with our ambition to not just become a market in sustainable protein solutions, but in the field of industrial biotechnology.

As the world increasingly turns towards sustainable alternatives, the market potential for Proton™ and other products in our pipeline is immense. The demonstration facility will accelerate our ability to bring Proton™ to market, whilst in parallel our R&D work on platform expansion will ensure that Aerbio remains at the cutting edge of the industry.

An Unstoppable Force in Biotechnology

We are unafraid to take risks because we have conviction in our vision and capabilities. Our relxentless passion for innovation and creative problem solving drives us to imagine what the future could be and inspires our partners and stakeholders to join us in this transformative journey.

We stand on the cusp of a new era in biotechnology—one where sustainability and profitability go hand in hand. The world is ready for change, and Aerbio is leading the charge. Are you ready to be part of Aerbio?

For investment enquiries, please email invest@aer.bio